Abstract
Curcumin is well known for its antimicrobial and anti-inflammatory properties. However, since systemic absorption and bioavailability of curcumin from gastrointestinal tract is considerably poor, synthetic curcuminoids are being developed as better alternatives. Two curcumin derivatives: 3,5-bis(benzylidene)-4-piperidone (EF24) and EF24-dimer linked via diethylenetriaminepentacetic acid (EF2DTPA), were included in this study. We investigated the antibacterial activity of EF24 and EF2DTPA against Gram-negative (Escherichia coli) and Gram-positive (Enterococcus faecalis, Staphylococcus aureus) bacteria. We also studied the effects of EF24 and EF2DTPA on uptake and localization of pHrodo-labeled E. coli in the acidic compartments (phagolysosomes) of dendritic cells (DCs) under in vitro conditions. Our results demonstrate that treatment with EF24 and EF2DTPA directly suppresses the bacterial growth. However, these compounds do not affect the bacterial uptake or localization in the DCs.
Similar content being viewed by others
References
Andersson, D. I. (2003). Persistence of antibiotic resistant bacteria. Current Opinion in Microbiology, 6, 452–456.
Wallace, R. J. (2004). Antimicrobial properties of plant secondary metabolites. Proceedings of the Nutrition Society, 63, 621–629.
Anand, P., Thomas, S. G., Kunnumakkara, A. B., Sundaram, C., Harikumar, K. B., Sung, B., et al. (2008). Biological activities of curcumin and its analogues (congeners) made by man and Mother Nature. Biochemical Pharmacology, 76, 1590–1611.
Mahady, G. B., Pendland, S. L., Yun, G., & Lu, Z. Z. (2002). Turmeric (curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Research, 22, 4179–4181.
Rudrappa, T., & Bais, H. P. (2008). Curcumin, a known phenolic from curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PAO1 in whole plant and animal pathogenicity models. Journal of Agricultural and Food Chemistry, 56, 1955–1962.
Kaur, S., Modi, N. H., Panda, D., & Roy, N. (2010). Probing the binding site of curcumin in Escherichia coli and Bacillus subtilis FtsZ–a structural insight to unveil antibacterial activity of curcumin. European Journal of Medicinal Chemistry, 45, 4209–4214.
Bhattacharyya, S., Md Sakib Hossain, D., Mohanty, S., Sankar Sen, G., Chattopadhyay, S., Banerjee, S., et al. (2010). Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts. Cellular & Molecular Immunology, 7, 306–315.
Zhao, C., Liu, Z., & Liang, G. (2013). Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs). Current Pharmaceutical Design, 19, 2114–2135.
Liang, G., Yang, S., Jiang, L., Zhao, Y., Shao, L., Xiao, J., et al. (2008). Synthesis and anti-bacterial properties of mono-carbonyl analogues of curcumin. Chemical & Pharmaceutical Bulletin (Tokyo), 56, 162–167.
Changtam, C., Hongmanee, P., & Suksamrarn, A. (2010). Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity. European Journal of Medicinal Chemistry, 45, 4446–4457.
Dubey, S. K., Sharma, A. K., Narain, U., Misra, K., & Pati, U. (2008). Design, synthesis and characterization of some bioactive conjugates of curcumin with glycine, glutamic acid, valine and demethylenated piperic acid and study of their antimicrobial and antiproliferative properties. European Journal of Medicinal Chemistry, 43, 1837–1846.
Mishra, S., Narain, U., Mishra, R., & Misra, K. (2005). Design, development and synthesis of mixed bioconjugates of piperic acid-glycine, curcumin-glycine/alanine and curcumin-glycine-piperic acid and their antibacterial and antifungal properties. Bioorganic & Medicinal Chemistry, 13, 1477–1486.
Hegge, A. B., Andersen, T., Melvik, J. E., Kristensen, S., & Tonnesen, H. H. (2010). Evaluation of novel alginate foams as drug delivery systems in antimicrobial photodynamic therapy (aPDT) of infected wounds–an in vitro study: studies on curcumin and curcuminoides XL. Journal of Pharmaceutical Sciences, 99, 3499–3513.
Hegge, A. B., Bruzell, E., Kristensen, S., & Tonnesen, H. H. (2012). Photoinactivation of Staphylococcus epidermidis biofilms and suspensions by the hydrophobic photosensitizer curcumin–effect of selected nanocarrier: studies on curcumin and curcuminoides XLVII. European Journal of Pharmaceutical Sciences, 47, 65–74.
Adams, B. K., Cai, J., Armstrong, J., Herold, M., Lu, Y. J., Sun, A., et al. (2005). EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism. Anti-Cancer Drugs, 16, 263–275.
Lagisetty, P., Powell, D. R., & Awasthi, V. (2009). Synthesis and structural determination of 3,5-bis(2-fluorobenzylidene)-4-piperidone analogs of curcumin. Journal of Molecular Structure, 936, 23–28.
Adams, B. K., Ferstl, E. M., Davis, M. C., Herold, M., Kurtkaya, S., Camalier, R. F., et al. (2004). Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents. Bioorganic & Medicinal Chemistry, 12, 3871–3883.
Kim, H. S., Cho, J. H., Park, H. W., Yoon, H., Kim, M. S., & Kim, S. C. (2002). Endotoxin-neutralizing antimicrobial proteins of the human placenta. Journal of Immunology, 168, 2356–2364.
Awasthi, S., Awasthi, V., Magee, D. M., & Coalson, J. J. (2005). Efficacy of antigen 2/proline-rich antigen cDNA-transfected dendritic cells in immunization of mice against Coccidioides posadasii. Journal of Immunology, 175, 3900–3906.
Awasthi, S., & Cox, R. A. (2003). Transfection of murine dendritic cell line (JAWS II) by a nonviral transfection reagent. Biotechniques, 35(600–602), 604.
Landegren, U. (1984). Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. Journal of Immunological Methods, 67, 379–388.
Awasthi, S., Madhusoodhanan, R., & Wolf, R. (2011). Surfactant protein-A and toll-like receptor-4 modulate immune functions of preterm baboon lung dendritic cell precursor cells. Cellular Immunology, 268, 87–96.
Rai, D., Singh, J. K., Roy, N., & Panda, D. (2008). Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochemical Journal, 410, 147–155.
Roth V (2006). Available from:http://www.doubling-time.com/compute.php
Vilekar, P., Awasthi, S., Natarajan, A., Anant, S., & Awasthi, V. (2012). EF24 suppresses maturation and inflammatory response in dendritic cells. International Immunology, 24, 455–464.
Underhill, D. M., & Goodridge, H. S. (2012). Information processing during phagocytosis. Nature Reviews Immunology, 12, 492–502.
Baliga, M. S., Joseph, N., Venkataranganna, M. V., Saxena, A., Ponemone, V., & Fayad, R. (2012). Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations. Food & Function, 3, 1109–1117.
Taylor, R. A., & Leonard, M. C. (2011). Curcumin for inflammatory bowel disease: a review of human studies. Alternative Medicine Review, 16, 152–156.
Yadav, V. R., Sahoo, K., Roberts, P. R., & Awasthi, V. (2013). Pharmacologic suppression of inflammation by a diphenyldifluoroketone, EF24, in a rat model of fixed-volume hemorrhage improves survival. Journal of Pharmacology and Experimental Therapeutics, 347, 346–356.
Acknowledgments
Authors acknowledge the contributions of Ms. Rose Cooper to this work as part of her undergraduate summer research training in SA’s laboratory at the University of Oklahoma Health Sciences Center, College of Pharmacy, Oklahoma City.
Contributions of Authors
PV performed experiments related to cell proliferation and phagocytosis, and CK performed antibacterial activity assays. PL synthesized EF24 and EF2DTPA. VA designed the steps related to synthesis of curcuminoids. SA designed the experiments related to antibacterial and phagocytic activity of curcuminoids and compiled the manuscript. All authors contributed to data analysis and writing of relevant sections in the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vilekar, P., King, C., Lagisetty, P. et al. Antibacterial Activity of Synthetic Curcumin Derivatives: 3,5-Bis(benzylidene)-4-Piperidone (EF24) and EF24-Dimer Linked via Diethylenetriaminepentacetic Acid (EF2DTPA). Appl Biochem Biotechnol 172, 3363–3373 (2014). https://doi.org/10.1007/s12010-014-0741-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-014-0741-5